The role of peripheral 5-HT1A, 5-HT1B, 5-HT1D, 5-HT1E and 5-HT1F serotonergic receptors in the reduction of nociception in rats

Neuroscience

Volumn 165, Issue 2, 2010, Pages 561-568

  Granados Soto, V ^a   Arguelles C F ^b   Rocha Gonzalez H I ^a   Godinez Chaparro B ^a   Flores Murrieta, F J ^c,d   Villalon C M ^a  

^a DEPARTAMENTO DE FÍSICA   (Mexico)

^b SECRETARÍA DE SALUD   (Mexico)

^c INSTITUTO POLITÉCNICO NACIONAL   (Mexico)

^d Unidad de Investigación en Farmacología   (Mexico)

Author keywords

5 HT1 receptor subtypes; hyperalgesia; inflammatory pain

Indexed keywords

2 DIPROPYLAMINO 5 FLUORO 8 HYDROXYTETRALIN; 2,3,6,7 TETRAHYDRO 1' METHYL 5 [[2' METHYL 4' (5 METHYL 1,2,4 OXADIAZOL 3 YL) 4 BIPHENYLYL]CARBONYL]SPIRO[FURO[2,3 F]INDOLE 3,4' PIPERIDINE]; 3 (1 METHYLPIPERIDINE 4 YL) 1H INDOL 5 OL MALEATE; 3 (3 DIMETHYLAMINOPROPYL) 4 HYDROXY N [4 (4 PYRIDINYL)PHENYL]BENZAMIDE; 3 [3 (2 DIMETHYLAMINOETHYL) 1H INDOL 5 YL] N (4 METHOXYBENZYL)ACRYLAMIDE; 3 [4 (3 CHLOROPHENYL) 1 PIPERAZINYL] 1,1 DIPHENYL 2 PROPANOL; 4 (4 METHYL 1 PIPERAZINYL) 7 TRIFLUOROMETHYLPYRROLO[1,2 A]QUINOXALINE; BRL 54443; FORMALDEHYDE; METITEPINE; N (3 DIMETHYLAMINO 2,3,4,9 TETRAHYDRO 1H CARBAZOL 6 YL) 4 FLUOROBENZAMIDE; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; N [3 (DIMETHYLAMINO) 2,3,4,9 TETRAHYDRO 1H CARBAZO LEVO 6 YL] 4 FLUOROBENZAMIDE; RECEPTOR SUBTYPE; SEROTONIN 1 AGONIST; SEROTONIN 1A RECEPTOR; SEROTONIN 1B RECEPTOR; SEROTONIN 1D RECEPTOR; SEROTONIN 1E RECEPTOR; SEROTONIN 1F RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANTIINFLAMMATORY ACTIVITY; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG DOSE INCREASE; DRUG RECEPTOR BINDING; DRUG SCREENING; ENZYME ACTIVATION; EXPERIMENTAL DESIGN; FEMALE; HINDLIMB; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 71949117509     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2009.10.020     Document Type: Article

References (71)

1. 1 receptor subtype coupled to the inhibition of adenylate cyclase. Proc Natl Acad Sci U S A 90 (1992) 408-412
2. Ahn A.H., and Basbaum A.I. Tissue injury regulates serotonin 1D receptor expression: implications for the control of migraine and inflammatory pain. J Neurosci 26 (2006) 8332-8338
3. Alhaider A.A., and Wilcox G.L. Differential roles of 5-hydroxytryptamine1A and 5-hydroxytryptamine1B receptor subtypes in modulating spinal nociceptive transmission in mice. J Pharmacol Exp Ther 265 (1993) 378-385
4. Aloisi A.M., Albonetti M.E., and Carli G. Sex differences in the behavioural response to persistent pain in rats. Neurosci Lett 179 (1994) 79-82
5. 1A receptor-mediated, behaviorally specific analgesia. Eur J Pharmacol 421 (2001) 109-114
6. 1D receptor agonist properties of novel 2-[5-[[(trifluoromethyl)sulfonyl]oxy]indolyl]ethylamines and their use as synthetic intermediates. J Med Chem 39 (1996) 4717-4726
7. 1B receptor cell line. Eur J Pharmacol 360 (1998) 17-121
8. Bingham S., Davey P.T., Sammons M., Raval P Overend P., and Parsons A.A. Inhibition of inflammation-induced thermal hypersensitivity by sumatriptan through activation of 5-HT1B/1D receptors. Exp Neurol 167 (2001) 65-73
9. Björk L., Fredriksson A., Hacksell U., and Lewander T. Effects of (R)-8-OH-DPAT and the enantiomers of UH-301 on motor activities in the rat: antagonism of (R)-8-OH-DPAT-induced effects. Eur Neuropsychopharmacol 2 (1992) 141-147
10. 1F receptors. Br J Pharmacol 123 (1998) 233
11. 1A receptor ligands-past and present. Curr Med Chem 12 (2005) 1721-1753
12. Cardenas C.G., Mar L.P., Vysokanov A.V., Arnold P.B., Cardenas L.M., Surmeier D.J., and Scroggs R.S. Serotonergic modulation of hyperpolarization-activated current in acutely isolated rat dorsal root ganglion neurons. J Physiol 518 (1999) 507-523
13. 1B/D receptor reduces hindlimb neurogenic inflammation caused by sensory nerve stimulation and capsaicin. Pain 134 (2008) 97-105
14. Castañeda-Corral G., Rocha-González H.I., Araiza-Saldaña C.I., Ambriz-Tututi M., Vidal-Cantú G.C., and Granados-Soto V. Role of peripheral and spinal 5-HT6 receptors according to the rat formalin test. Neuroscience 162 (2009) 444-452
15. Chen J.J., Vasko M.R., Wu X., Staeva T.P., Baez M., Zgombick J.M., and Nelson D.L. Multiple subtypes of serotonin receptors are expressed in rat sensory neurons in culture. J Pharmacol Exp Ther 287 (1998) 1119-1127
16. 1D receptor subtypes mediating cerebral vasoconstriction. Cephalagia 15 Suppl 14 (1995) 99
17. 1D (BRL15572) receptor antagonists. Eur J Pharmacol 362 (1998) 69-72
18. Doak G.J., and Sawynok J. Formalin-induced nociceptive behavior and edema: involvement of multiple peripheral 5-hydroxytryptamine receptor subtypes. Neuroscience 80 (1997) 939-949
19. Dubuisson D., and Dennis S.G. The formalin test: a quantitative study of the analgesic effect of morphine, meperidine, and brain stem stimulation in rats and cats. Pain 4 (1977) 161-174
20. 1B receptors and 5-hydroxytryptamine uptake inhibition in the cocaine-evoked discriminative stimulus effects in rats. J Physiol Pharmacol 52 (2001) 249-263
21. 1A receptor antagonist. Behav Brain Res 73 (1996) 337-353
22. 1A receptor antagonist, WAY-100635. Eur J Pharmacol 281 (1995) 81-88
23. Fozard J.R., Mir A.K., and Middlemiss D.N. Cardiovascular response to 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) in the rat: site of action and pharmacological analysis. J Cardiovasc Pharmacol 9 (1987) 328-347
24. Gaumond I., Arsenault P., and Marchand S. The role of sex hormones on formalin-induced nociceptive responses. Brain Res 958 (2002) 139-145
25. + current in nociceptors. Proc Natl Acad Sci U S A 93 (1996) 1108-1112
26. 1B receptors causes hypothermia in the guinea pig. Eur J Pharmacol 331 (1997) 169-174
27. Hannon J., and Hoyer D. Molecular biology of 5-HT receptors. Behav Brain Res 195 (2008) 198-213
28. Holz G.G., Shefner S.A., and Anderson E.G. Serotonin depolarizes type A and C primary afferents: an intracellular study in bullfrog dorsal root ganglion. Brain Res 327 (1985) 71-79
29. Hoyer D., Clarke D.E., Fozard J.R., Hartig P.R., Martin G.R., Mylecharane E.J., Saxena P.R., and Humphrey P.P. International union of pharmacology classification of receptors for 5-hydroxytryptamine (serotonin). Pharmacol Rev 46 (1994) 157-203
30. Ireland S.J., and Jordan C.C. Pharmacological characterization of 5-hydroxytryptamine-induced hyperpolarization of the rat superior cervical ganglion. Br J Pharmacol 92 (1987) 417-427
31. Jeong C.Y., Choi J.I., and Yoon M.H. Roles of serotonin receptor subtypes for the antinociception of 5-HT in the spinal cord of rats. Eur J Pharmacol 502 (2004) 205-211
32. 1A receptor antagonist, NAD-299. J Pharmacol Exp Ther 283 (1997) 216-225
33. 1F receptor agonists inhibit neurogenic dural inflammation in guinea pigs. Neuroreport 8 (1997) 2237-2240
34. 3A-/- and 5-HTT-/- knock-out male mice. Pain 130 (2007) 235-248
35. 1B antagonists by chemical modulation of 3-[3-(N,N-dimethylamino)propyl]-4-hydroxy-N-[4-(pyridin-4-yl)phenyl]benz amide (GR-55562). J Med Chem 40 (1997) 3542-3550
36. 3 receptors in the rat spinal cord. J Neural Transm Gen Sect 100 (1995) 207-223
37. Liu F.Y., Xing G.G., Qu X.X., Xu I.S., Han J.S., and Wan Y. Roles of 5-hydroxytryptamine (5-HT) receptor subtypes in the inhibitory effects of 5-HT on C-fiber responses of spinal wide dynamic range neurons in rats. J Pharmacol Exp Ther 321 (2007) 1046-1053
38. Liu X.Y., Wu S.X., Wang Y.Y., Wang W., Zhou L., and Li Y.Q. Changes of 5-HT receptor subtype mRNAs in rat dorsal root ganglion by bee venom-induced inflammatory pain. Neurosci Lett 375 (2005) 42-46
39. Millan M.J. The induction of pain: an integrative review. Prog Neurobiol 57 (1999) 1-164
40. Millan M.J. Descending control of pain. Prog Neurobiol 66 (2002) 355-474
41. 1A receptors does not elicit antinociception against noxious thermal, mechanical and chemical stimuli in mice. Pain 58 (1994) 45-61
42. 1A agonists and antagonists in rodents: relationship to algesiometric paradigm. Behav Brain Res 73 (1996) 69-77
43. 1F receptors modulate c-fos expression within rat trigeminal nucleus caudalis. Eur J Pharmacol 369 (1999) 271-277
44. 1B receptors in spinal nociceptive transmission and in the modulation of NMDA induced behaviour. Neuroreport 3 (1992) 1061-1064
45. 1A receptor agonist flesinoxan in pigeons. Eur J Pharmacol 325 (1997) 145-153
46. Nakajima K., Obata H., Ito N., Goto F., and Saito S. The nociceptive mechanism of 5-hydroxytryptamine released into the peripheral tissue in acute inflammatory pain in rats. Eur J Pain 13 (2009) 441-447
47. Neale R.F., Fallon S.L., Boyar W.C., Wasley J.W., Martin L.L., Stone G.A., Glaeser B.S., Sinton C.M., and Williams M. Biochemical and pharmacological characterization of CGS 12066B, a selective serotonin-1B agonist. Eur J Pharmacol 136 (1987) 1-9
48. Nicholson R., Small J., Dixon A.K., Spanswick D., and Lee K. Serotonin receptor mRNA expression in rat dorsal root ganglion neurons. Neurosci Lett 337 (2003) 119-122
49. Nikai T., Basbaum A.I., and Ahn A.H. Sumatriptan regulates non-trigeminal pain in the setting of inflammation. Soc Neurosci Abstr 31 (2001) 511 28
50. 3 receptor attenuates the formalin-induced nocifensive behavior in persistent temporomandibular joint inflammation of rat. Neurosci Lett 367 (2004) 259-263
51. 1A receptor-mediated locomotor activity in the guinea pig. Eur J Pharmacol 370 (1999) 85-92
52. Oyama T., Ueda M., Kuraishi Y., Akaike A., and Satoh M. Dual effect of serotonin on formalin-induced nociception in the rat spinal cord. Neurosci Res 25 (1996) 129-135
53. 1B receptors. Naunyn Schmiedeberg's Arch Pharmacol 353 (1996) 144-156
54. 1F receptors: binding affinities, brain penetration and activity in the neurogenic dural inflammation model of migraine. Life Sci 61 (1997) 2117-2126
55. Pierce P.A., Xie G.X., Peroutka S.J., and Levine J.D. Dual effect of the serotonin agonist, sumatriptan, on peripheral neurogenic inflammation. Reg Anesth 21 (1996) 219-225
56. Pierce P.A., Xie G.X., Levine J.D., and Peroutka J. 5-hydroxytryptamine receptor subtype messenger RNAs in rat peripheral sensory and sympathetic ganglia: a polymerase chain reaction study. Neuroscience 70 (1996) 553-559
57. Potrebic S., Ahn A.H., Skinner K., Fields H.L., and Basbaum A.I. Peptidergic nociceptors of both trigeminal and dorsal root ganglia express serotonin 1D receptors: implications for the selective antimigraine action of triptans. J Neurosci 23 (2003) 10988-10997
58. 1D receptors. Naunyn Schmiedebergs Arch Pharmacol 356 (1997) 312-320
59. 7 receptors in the formalin test. Pain 117 (2005) 182-192
60. 1B receptor antagonist with negative intrinsic activity. Br J Pharmacol 125 (1998) 202-208
61. 1F receptor agonist LY334370. Cephalalgia 19 (1999) 851-858
62. 1D receptors causes hypothermia in the guinea-pig. J Psychopharmacol 8 (1994) 14-21
63. Taiwo Y.O., and Levine J.D. Serotonin is a directly-acting hyperalgesic agent in the rat. Neuroscience 48 (1992) 485-490
64. 1A receptors. Brain Res 585 (1992) 212-218
65. Villalón C.M., and Centurión D. Cardiovascular responses produced by 5-hydroxytryptamine: a pharmacological update on the receptors/mechanisms involved and therapeutic implications. Naunyn Schmiedeberg's Arch Pharmacol 376 (2007) 45-63
66. Wheeler-Aceto H., and Cowan A. Standardization of the rat paw formalin test for the evaluation of analgesics. Psychopharmacology 104 (1991) 35-44
67. Wu S., Zhu M., Wang W., Wang Y., Li Y., and Yew D.T. Changes of the expression of 5-HT receptor subtype mRNAs in rat dorsal root ganglion by complete Freund's adjuvant-induced inflammation. Neurosci Lett 307 (2001) 183-186
68. Zgombick J.M., Schechter L.E., Macchi M., Hartig P.R., Branchek T.A., and Weinshank R.L. Human gene S31 encodes the pharmacologically defined serotonin 5-hydroxytryptamine1E receptor. Mol Pharmacol 42 (1992) 180-185
69. 1A receptor mRNA in rat lumbar spinal dorsal horn neurons after peripheral inflammation. Pain 98 (2002) 287-295
70. Zimmermann M. Ethical guidelines for investigations on experimental pain in conscious animals. Pain 16 (1983) 109-110
71. Zochodne D.W., and Ho L.T. Sumatriptan blocks neurogenic inflammation in the peripheral nerve trunk. Neurology 44 (1994) 161-163